Search Results for "Transgene Tasly"
Original Source: Transgene and Tasly JV Starts Operations with Four Transgene Molecules
The JV established by France’s Transgene and Tasly Pharma of China announced that Transgene is contributing China rights to four biotech immunotherapeutic candidates to the JV. The JV will be capitalized with $3.2 million from Transgene and...
Matching Channels
None
Matching News
Transgene and Tasly JV Starts Operations with Four Transgene Molecules
The JV established by France’s Transgene and Tasly Pharma of China announced that Transgene is contributing China rights to four biotech immunotherapeutic candidates to the JV. The JV will be...
Transgene, Tasly Pharmaceutical deal
Tasly Pharma Buys 100% of TaslyDiyi Pharma
Tasly Pharmaceutical, a company known mainly for its TCM products, paid 1.5 billion RMB ($240 million) to acquire Jiangsu TaslyDiyi Pharmaceutical, a maker of chemical drugs. TaslyDiyi was 75% owned b...
Sanofi and Transgene enter biotech partnering
Sanofi and Transgene announced a biotech partnering agreement for the creation of a new state-of-the-art industrial platform dedicated to the production of immunotherapy products including Transgeneâ€...
Week in Review: Suzhou Connect Biopharma In-Licenses Anti-Inflammatories from Arena
Suzhou Connect Biopharma, a new startup, in-licensed two series of anti-inflammatory compounds from Arena Pharma of San Diego; Transgene of France and China’s Tasly Pharma announced their JV w...
India's Transgene Biotek claims early success in oral insulin for rats
The Indian company, Transgene Biotek, has reported encouraging early results for its oral delivery technology for insulin, though industry experts say it may be premature to flag up the progress made...
Sanofi, Transgene Announce Agreement For Creation Of Industrial Platform
PARIS (dpa-AFX) - Sanofi (SNY) and Transgene SA announced a collaboration agreement for the creation of an industrial platform for the production of immunotherapy products including Transgene's th...
Sanofi and Transgene collaborate on immunotherapy treatments; NAS designation of Aubagio disputed
Drug major Sanofi (Euronext: SAN) and fellow France-based biotech firm Transgene SA (NYSE-Euronext: TNG) have entered a collaboration agreement for the creation of a new state-of-the-art industrial pl...
Matching PubMed Articles
An endogene-resembling transgene delays the onset of silencing and limits siRNA accumulation.
In plants, transgenes are generally more sensitive against RNA silencing than endogenes are. In this study, we generated a transgene that structurally mimicks an endogene. It is composed of endogenous...
In quiescent tissues, minicircle DNA vectors provide at least 10 times higher sustained levels of transgene expression compared to that achieved with a canonical plasmid containing the same expression...
A Mini-intronic Plasmid (MIP): A Novel Robust Transgene Expression Vector In Vivo and In Vitro.
The bacterial backbone (BB) sequences contained within a canonical plasmid DNA dampen exogenous transgene expression by tenfold to 1,000-fold over a period of a few weeks following transfection into q...
Multiple components in serum contribute to hepatic transgene expression by lipoplex in mice.
BACKGROUND: Interaction of cationic liposome/plasmid DNA complex (lipoplex) with serum was not a limiting factor for in vivo transfection. Following intraportal injection of lipoplex, hepatic transgen...
Endogenous microRNA (miRNA) expression can be exploited for cell type-specific transgene expression as the addition of miRNA target sequences to transgenic cDNA allows for transgene downregulation spe...
